Pradžia › Nemiga › Pennsylvania
Nemiga klinikiniai tyrimai Pennsylvania
7 tyrimai dėl Nemiga ieško dalyvių vietose Pennsylvania.
Miestai Pennsylvania
Oficialus tyrimo tekstas (anglų kalba)
A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)
- Penn Medicine University of Pennsylvania Health System- Center for Studies of Addiction ( Site 1006), Philadelphia
Renkami dalyviai3 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-21 · NCT06655883A SMART Approach to Evaluating the Benefits of Common Prescription and OTC Medications for Insomnia
- University of Pennsylvania, Philadelphia
Renkami dalyviai4 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-16 · NCT07542756Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
- Clinical Research Site, Wyomissing
Renkami dalyviai3 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-07-24 · NCT06568367Virtual Reality to Reduce Anxiety, Agitation and Delirium in Critically Ill Patients
- Penn State Milton S. Hershey Medical Center, Hershey
Renkami dalyviaiLaukiami sveiki savanoriai
Visi amžiai · Visoms lytims · Atnaujinta 2026-06-22 · NCT07649876Comparing Digital Therapy, Trazodone, and Daridorexant for Menopause-Related Insomnia Symptoms
- University of Pittsburgh Medical Center, Pittsburgh
Renkami dalyviai4 fazė
Amžius nuo 40 iki 62 · Moterims · Atnaujinta 2026-06-08 · NCT07136415Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia
- Penn State University, Hershey
- University of Pittsburgh, Pittsburgh
Renkami dalyviaiAnkstyvoji 1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-11-10 · NCT06281756Insomnia Behavioral Intervention Study
- University of Pennsylvania School of Medicine, Philadelphia
Renkami dalyviai
Amžius nuo 55 iki 85 · Visoms lytims · Atnaujinta 2025-07-17 · NCT05301543Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.